MedPath

Neonatal Seizure Registry - Developmental Functional EValuation

Active, not recruiting
Conditions
Epilepsy
Cerebral Palsy
Stroke
Neonatal Seizure
Intracranial Hemorrhages
Hypoxic-Ischemic Encephalopathy
Intellectual Disability
Registration Number
NCT04337697
Lead Sponsor
University of California, San Francisco
Brief Summary

The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.

Detailed Description

Neonatal seizures due to brain injury (acute symptomatic seizures) are associated with high risk of neurodevelopmental disability in infancy. Although prognosis in early childhood is a critical question for parents and providers, outcomes beyond infancy are largely unknown. Further, parents of infants with neonatal seizures are at risk for mental health disorders, which can undermine their ability to care for a child with medical complexity and may contribute to impaired child development.

The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants enrolled at one of nine sites across the USA. Participants will be evaluated using developmental questionnaires and in-person neurodevelopmental testing. Parent well-being will be assessed at each time point.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
280
Inclusion Criteria
  • Enrolled in NSR-II
  • Alive at the start of the NSR-DEV study period
  • Parent(s) who are English or Spanish literate (with assistance of interpreter)
Read More
Exclusion Criteria
  • Neonates who were found to have exclusion criteria after NSR-II enrollment
  • Risk for adverse outcome independent of seizures and underlying brain injury (including but not limited to: inborn errors of metabolism, fetal infection, brain malformation)
  • Transient cause for seizures (e.g., mild hypoglycemia, hyponatremia, hypocalcemia with normal neuroimaging)
  • Neonatal-onset epilepsy syndromes
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Full scale IQ (FSIQ) score for each child on the Wechsler Preschool and Primary Scale of Intelligence, 4th Edition (WPPSI-IV)At age 5.5 years during in-person study visit

The WPPSI-IV is an in-person assessment administered by a psychologist or psychometrician that will be used to measure neurocognitive ability. Full Scale IQ (FSIQ) will be generated for each participant from the following subtests: Verbal Comprehension Index (VCI), Visual Spatial Index (VSI), Fluid Reasoning Index (FRI), Working Memory Index (WMI), Processing Speed Index (PSI), Receptive Vocabulary and Picture Naming.

Secondary Outcome Measures
NameTimeMethod
Change in scores over time for each child on the Vineland Adaptive Behavior Scales, 3rd EditionAt enrollment study visit and annual visits when the child is age 3, 4, 5.5, 7, and 8

The Vineland Adaptive Behavior Scales Parent Form measures adaptive behavior and intellectual and developmental function. Adaptive behavior is predictive of functional performance in school and is linked to both cognitive and executive function. Scores for each participant at each timepoint are generated based on parent reports in the following categories: Communication, Daily Living Skills, Socialization, Motor Skills, Adaptive Behavior Composite (ABC). We will look at the change in score over time for each participant during the study period after the Vineland-3 is administered at each timepoint.

Trial Locations

Locations (9)

Stanford University

๐Ÿ‡บ๐Ÿ‡ธ

Stanford, California, United States

Cincinnati Children's Hospital Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Cincinnati, Ohio, United States

Children's Hospital of Philadelphia

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

University of Michigan

๐Ÿ‡บ๐Ÿ‡ธ

Ann Arbor, Michigan, United States

Duke University

๐Ÿ‡บ๐Ÿ‡ธ

Durham, North Carolina, United States

Boston Children's Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Children's National Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Washington, District of Columbia, United States

University of California, San Francisco

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco, California, United States

Massachusetts General Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath